Sarah Cappuyns

机构：Hammersmith Hospital, KU Leuven · ORCID：0000-0002-4521-2504

发表论文 46 篇 · 总被引 519 次 · h-index 8

代表论文

• Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 60)
• NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma (2024 · Cancer Discovery · 被引 12)
• Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment (2025 · Cell Reports Medicine · 被引 8)
• A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
• Claudin-18.2 expression in gastro-oesophageal adenocarcinoma in a Western population: Overlap with other biomarkers and prognostic value. (2025 · Journal of Clinical Oncology · 被引 2)
• Systemic treatment paradigms for unresectable and advanced hepatocellular carcinoma in Europe (2026 · The Lancet Regional Health - Europe · 被引 1)